WHAT ARE THE BENEFITS OF TAKING A DISTANCE LEARNNG PROGRAM IN PHARMA REGULATORY AFFAIRS?
The Program is with updated technology and one can study anytime anywhere from the Institute.You can quickly obtain a practical understanding of the regulatory processes in specific target markets, ensuring your products conform to regional standards. As regulations and directives are amended, you’ll be able to trace each step of the process. You’ll gain a unique insight into the pharmaceutical market. You’ll make more informed reports to strategic planning and change management groups, and write better and faster compliance submissions
CAREERS IN PHARMA REGULATORY AFFAIRS ?
Graduates from this Distance Learning program may pursue careers in the areas
of Regulatory Affairs and Quality Operations. Career options include the
pharmaceutical, biotechnological, veterinary, cosmetic and food industries.
Graduates will find employment as
· Regulatory Affairs Associates
· Regulatory Affairs Assistants
· Quality Assurance Associates
· Quality Assurance Investigators
· Documentation Administrators and
· Medical Information Associates
· In Contract Research Organization(CRO) Pharma regulatory affairs professionals are responsible for maintaining records of Common Technical Documents for Pharmaceutical Dossiers.
HOW DOES REGULATORY AFFAIRS CERTIFICATION ENHANCES SOMEONE’S EMPLOYMENT PROSPECTS ?
“Certified professionals "earn anywhere from 20 to 30% more than their peers. In addition, many companies--both large and small to midsize--are now beginning to indicate that REGULATORY AFFAIRS CERTIFICATION is a desirable qualification."
JOIN DISTANCE LEARNING PROGRAM IN PHARMA RUGULATORY AFFAIR AS A CAREER
A real advantage of a career in this area is that you get a holistic view of a drug’s
development. Act as intermediate with so many different people, from drug
development teams through to people in marketing and legal affairs, as well as
external health authorities, you serve as a Backbone – holding the whole operation
together.
For Latest News And Professional Information On Pharma Regulatory Affairs,Read Daily Updates and Pharma Regulatory Affairs Presentation On Blog
2 comments:
Dear Sir,
As today result of april examination was declared;I was told on phone that i have got 21 marks in schedule Y paper and i have not passed the subject.I would like to draw your attention to below mentioned points and request you for reevaluation......
1. I appeared in nov. 2007 exam. and cleared six papers with good percentage.
2. I scored 44 marks in schedule y paper .
3.In april; I appeared and question paper was same[schedule Y]
4.I attempted much better than nov. exam.
5. Now you say I have scored 21 marks
So in a way you are prolonging my completion by 9 months.
1. your evaluation system is seriously flawed,If i could not pass
this time I did not deserve to pass in previous six papers.YOU can VERIFY my claim by COMPARING my all answer sheets.
2. I am well settled in my profession as ENT surgeon.Main purpose of my joining the course was to get compiled study material to help in my research. IF you could do such bizarre result to me Then I am afraid about plight of young innocent students.KINDLY look in to the matter with an analytical and sypathetic thinking.I have also done online course in BIOINFORMATICS in 2006 from this institute. Kindly tell me WHICH REDRESSAL OR AFFILIATION AUTHORITY SHOULD I CONTACT
Dr. Ashish Batra A06ICRC10034
MBBS DLO DNB [ OTORHINOLARYNGOLOGY]
Mob.
Dear Ashish Batra
Let's remove all the confusion,Finally you have scored 84 marks and for further clarification Please contact ADMIN
Post a Comment